BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36321189)

  • 1. Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.
    Schneider L; Dansranjav T; Neumann E; Yan H; Pilatz A; Schuppe HC; Wagenlehner F; Schagdarsurengin U
    Mol Oncol; 2023 Mar; 17(3):445-468. PubMed ID: 36321189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cells derived exosomal miR-203a-3p facilitates stromal inflammation of type IIIA chronic prostatitis/chronic pelvic pain syndrome by targeting DUSP5 and increasing MCP-1 generation.
    Song G; Zhao F; Ni R; Deng B; Chen S; Hu R; Zheng J; Peng Y; Liu H; Luo Y; Zhou Z; Huang G; Shen W
    J Nanobiotechnology; 2024 May; 22(1):236. PubMed ID: 38724995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS.
    Berger RE; Ciol MA; Rothman I; Turner JA
    BMC Urol; 2007 Oct; 7():17. PubMed ID: 17908331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls.
    Nickel JC; Alexander RB; Schaeffer AJ; Landis JR; Knauss JS; Propert KJ;
    J Urol; 2003 Sep; 170(3):818-22. PubMed ID: 12913707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
    Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
    Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
    Zhao Z; Xuan X; Zhang J; He J; Zeng G
    J Sex Med; 2014 Oct; 11(10):2528-36. PubMed ID: 24735240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of immune factor between patients with chronic prostatitis/chronic pelvic pain syndrome and the healthy volunteers.
    Ye C; Xiao G; Xu J; Qin S; Luo Y; Chen G; Lai HH; Zhou T
    Int Urol Nephrol; 2018 Mar; 50(3):395-399. PubMed ID: 29235061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel and simple approach to distinguish chronic prostatitis/ chronic pelvic pain syndrome IIIb from IIIa using virtual touch tissue quantification.
    Zheng X; Ji P; Mao H; Wu J
    Bosn J Basic Med Sci; 2011 Nov; 11(4):205-8. PubMed ID: 22117824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic fluid exosome-mediated microRNA-155 promotes the pathogenesis of type IIIA chronic prostatitis.
    Zhao B; Zheng J; Qiao Y; Wang Y; Luo Y; Zhang D; Cai Q; Xu Y; Zhou Z; Shen W
    Transl Androl Urol; 2021 May; 10(5):1976-1987. PubMed ID: 34159078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-κB, MAPKs, and Nrf2 signaling pathways in rats.
    Zhao Q; Yang F; Meng L; Chen D; Wang M; Lu X; Chen D; Jiang Y; Xing N
    Andrology; 2020 May; 8(3):747-755. PubMed ID: 31880092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
    Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD012551. PubMed ID: 29372565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
    Franco JV; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012551. PubMed ID: 29757454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of microRNAs in expressed prostatic secretion of healthy men and patients with IIIA chronic prostatitis/chronic pelvic pain syndrome.
    Chen Y; Chen S; Zhang J; Wang Y; Jia Z; Zhang X; Han X; Guo X; Sun X; Shao C; Wang J; Lan T
    Oncotarget; 2018 Feb; 9(15):12186-12200. PubMed ID: 29552302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome.
    Nadler RB; Collins MM; Propert KJ; Mikolajczyk SD; Knauss JS; Landis JR; Fowler JE; Schaeffer AJ; Alexander RB;
    Urology; 2006 Feb; 67(2):337-42. PubMed ID: 16442595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Polymorphisms of
    Chen L; Chen J; Mo F; Bian Z; Jin C; Chen X; Liang C
    Dis Markers; 2021; 2021():2898336. PubMed ID: 34646402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astaxanthin alleviates chronic prostatitis/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine.
    Liu YF; Xie WJ; Xi P; Zhang ZC; Chen R; Fu SQ; Lei KY; Liu J; Cheng XF; Nie YC; Yang XR; Ma M; Sun T; Gong BB
    Phytomedicine; 2024 Jan; 123():155249. PubMed ID: 38056144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.
    Pontari MA
    Drugs Aging; 2003; 20(15):1111-25. PubMed ID: 14651434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostatic secretion microbiota: a comparative analysis of the hronical prostatitis II and IIIA category].
    Kogan MI; Naboka YL; Ismailov RS
    Urologiia; 2020 Apr; (2):16-22. PubMed ID: 32351058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y; Eroğlu O
    Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.